09 February 2021 : Clinical Research
Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience
Vanessa Nader12ABCDEF, Anthony Matta13ABDEF, Ronan Canitrot1ADEF, Romain Itier1DEF, Pascale Salameh2ACF, Olivier Lairez1EF, Meyer Elbaz1AEF, Michel Galinier1AEF, Rania Azar2ADEF, Jerome Roncalli1ADEF*DOI: 10.12659/MSM.928218
Med Sci Monit 2021; 27:e928218
Table 4 Distribution of valvular heart disease according to types of left ventricular dysfunction.
| Diastolic dysfunction | Systolic dysfunction | ||||||
|---|---|---|---|---|---|---|---|
| No | Yes | P value | No | Yes | P value | ||
| No | 1410, 78% | 1670, 62% | <0.001 | 2580, 70% | 500, 62% | <0.001 | |
| Yes | 405, 22% | 1035, 38% | 1130, 30% | 310, 38% | |||
| No | 1485, 82% | 1995, 74% | <0.001 | 2900, 78% | 580, 72% | <0.001 | |
| Yes | 330, 18% | 710, 26% | 810, 22% | 230, 18% | |||
| No | 1730, 95% | 2390, 88% | <0.001 | 3395, 92% | 725, 90% | 0.69 | |
| Yes | 85, 5% | 315, 12% | 315, 8% | 85, 10% | |||
| No | 1090, 60% | 1280, 47% | <0.001 | 2125, 57% | 245, 30% | <0.001 | |
| Yes | 725, 40% | 1425, 53% | 1585, 43% | 565, 70% | |||
| No | 1115, 61% | 1305, 48% | <0.001 | 2145, 58% | 275, 34% | <0.001 | |
| Yes | 700, 39% | 1400, 52% | 1565, 42% | 535, 66% | |||
| No | 1800, 99% | 2670, 99% | 0.14 | 3685, 99% | 785, 97% | <0.001 | |
| Yes | 15, 1% | 35, 1% | 25, 1% | 25, 3% | |||
| No | 1540, 85% | 2010, 74% | <0.001 | 2990, 81% | 560, 69% | <0.001 | |
| Yes | 275, 15% | 695, 26% | 720, 19% | 250, 31% | |||
| No | 1115, 61% | 1535, 57% | 0.002 | 2255, 61% | 395, 49% | <0.001 | |
| Yes | 700, 39% | 1170, 43% | 1455, 39% | 415, 51% | |||
| AMVD – aorto-mitral valve disease; AVD – aortic valve disease; AVR – aortic valve regurgitation; AVS – aortic valve stenosis; MVD – mitral valve disease; MVR – mitral valve regurgitation; MVS – mitral valve stenosis; TR – tricuspid regurgitation. | |||||||






